Emergent BioSolutions to Present at 31st Annual J.P. Morgan Healthcare Conference

  Emergent BioSolutions to Present at 31st Annual J.P. Morgan Healthcare
  Conference

Business Wire

ROCKVILLE, Md. -- December 03, 2012

Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the
company’s senior management team will provide a corporate overview
presentation at the 31^st Annual J.P. Morgan Healthcare Conference in San
Francisco on Tuesday, January 8, 2013 at 10:00AM Pacific.  The presentation
may include a discussion of recent business developments, preliminary 2012
financial results and financial guidance for full year 2013.

A webcast of this presentation will be available both live and by replay,
accessible from the Emergent website www.emergentbiosolutions.com under
“Investors”.

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty pharmaceutical company seeking to protect
and enhance life by offering specialized products to healthcare providers and
governments to address medical needs and emerging health threats. Additional
information about us may be found at www.emergentbiosolutions.com.

Follow us on twitter: @emergentbiosolu.

Contact:

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com
 
Press spacebar to pause and continue. Press esc to stop.